What should you do if youre taking an unapproved GLP-1
A clinical assessment can help you figure out whether GLP-1 therapy makes sense on its own or alongside other treatments
Image Credit: azimmytws / Shutterstock.com A recent BMJ study determines whether the use of glucagon-like peptide-1 (GLP-1) receptor agonists by type 2 diabetes (T2D) patients increases the risk of self-harm, suicidal ideation, and suicide as compared to patients prescribed dipeptidyl peptidase-4 (DPP-4) or sodium-glucose cotransporter-2 (SGLT-2) inhibitors
Esses avanos representam esperana para milhes de pessoas em todo o mundo que lutam com essas condies, oferecendo-lhes novas opes de tratamento e melhor qualidade de vida (PAULA, 2021)
Tirzepatide for treating type 2 diabetes TA924
Key points for patients: GLP-1 therapies help clear skin and reduce painful, swollen joints Obesity makes PsA harder to treat, so weight loss from GLP-1 meds helps In studies, patients on GLP-1s had fewer flares, less pain, and felt better overall